First National Bank of South Miami’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$138K Hold
1,366
0.11% 146
2023
Q1
$126K Hold
1,366
0.1% 154
2022
Q4
$124K Hold
1,366
0.09% 157
2022
Q3
$104K Hold
1,366
0.08% 164
2022
Q2
$115K Hold
1,366
0.08% 170
2022
Q1
$120K Hold
1,366
0.07% 171
2021
Q4
$119K Hold
1,366
0.07% 172
2021
Q3
$112K Hold
1,366
0.08% 162
2021
Q2
$125K Hold
1,366
0.09% 154
2021
Q1
$117K Hold
1,366
0.09% 148
2020
Q4
$129K Hold
1,366
0.11% 131
2020
Q3
$119K Hold
1,366
0.11% 132
2020
Q2
$119K Hold
1,366
0.13% 126
2020
Q1
$113K Hold
1,366
0.14% 122
2019
Q4
$129K Hold
1,366
0.13% 125
2019
Q3
$123K Hold
1,366
0.12% 134
2019
Q2
$125K Sell
1,366
-158
-10% -$13.4K 0.12% 135
2019
Q1
$131K Hold
1,524
0.13% 128
2018
Q4
$120K Buy
+1,524
New +$119K 0.12% 134

Other funds holding NVS

First National Bank of South Miami's NVS Position: Q2 2023 in Review

First National Bank of South Miami held its Novartis (NVS) position steady in Q2 2023 at 1,366 shares worth $138K. The position accounts for 0.11% of the portfolio, ranked #146.

First National Bank of South Miami first reported a position in NVS in Q4 2018 and has held it in 19 quarters since. 1,203 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • First National Bank of South Miami held 1,366 shares of Novartis worth $138K as of Q2 2023.
  • First National Bank of South Miami left its Novartis share count unchanged in Q2 2023.
  • Novartis made up 0.11% of First National Bank of South Miami's portfolio in Q2 2023, its #146 holding.
  • First National Bank of South Miami first reported a position in Novartis in Q4 2018 and has held it in 19 quarters since.
  • 1,203 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.